$IMMB ALERT OUT  IMMB Alerted Moments ago Immunotech

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker

$IMMB ALERT OUT >>  IMMB Alerted Moments ago >> Immunotech Laboratories - IMMB Hello Subscribers, Our Newly featured ALERT: IMMB NEW ALERT: Immunotech Laboratories, Inc (IMMB) - .22 JUST RELEASED VIDEO with Bo Linton: http://clicks.aweber.com/y/ct/l=DFs9Q&m=3...0CeGQWmgTg Begin your research here: http://clicks.aweber.com/y/ct/l=DFs9Q&m=3...3o_4sO1rDA http://clicks.aweber.com/y/ct/l=DFs9Q&m=3...14mT9ryaTw IMMB is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Immunotech is committed to creating drugs for the better health of mankind.


Immunotech`s flagship compound ITV-1 (Immune Therapeutic Vaccine-1) is a suspension of Inactivated Pepsin Fraction (IPF), which studies have shown is effective in the treatment of HIV/AIDS. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. 

How treatment works is: IMMB offers this innovative HIV / AIDS drug, Irreversible Pepsin Fraction (IPF) a platform technology that can be used to facilitate a broad range of applications. 

It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. Read more... [ http://clicks.aweber.com/y/ct/l=DFs9Q&m=3...A7X3egjgeg ]Treatments for HIV patients are low cost: less than 500 per treatment and only 3 treatments necessary. Thats remarkable! considering that the cost is less than most peoples medical insurance deductibles these days. 

There are approx. 30 million people in Africa alone who suffer from HIV/AIDS. 

According to Director Bo Linton in an interview with Undiscovered Companies, [  http://clicks.aweber.com/y/ct/l=DFs9Q&m=3...0CeGQWmgTg ] potential revenues from HIV treatment when in full production is an astounding 750 per person worldwide. Multiply that by the number of HIV/AIDS patients across the world!!! This does not even include cancer cures. 

IMMB recently announced that it had been in negotiations with an International Bio-Tech Partner in the HIV cure technology sector for joint advanced Research & Development and the partner has agreed to provide the necessary funding for the USA Clinical Trials phases to ultimately achieve FDA approval for the medicines. 

The terms include some exclusive rights for the International partner for use and distribution of the vaccines in several countries where the equivalent of FDA approval is not required and can be distributed and administered labeled as an "Experimental Drug". This process will help accelerate the clinical trials results. Read more... [ http://clicks.aweber.com/y/ct/l=DFs9Q&m=3...URzlFXR.wA ]Follow the CROWD and quickly put IMMB on your Watch List. With a float of only approx. 1 million shares, IMMB could be one of the most highly undervalued Medical Science plays on the small cap market. IMMB actually helps people. Their HIV treatment can save millions of lives as well as prevent prolonged suffering associated with HIV patients. 

Read more:  http://stockreads.com/Stock-Newsletter.aspx?i...z2Jye653YK

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 6

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 3

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 3

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 8

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 4

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading

Top 5 Most Recently Viewed Articles

Impact of Rising Medical Costs on Major Insurers Post-COVID

Updated Category News Views 97

Understanding the Financial Struggles of Major Insurers In the aftermath of the COVID-19 pandemic, several large insurers have been grappling with inflation in medical expenses, especially within their government-sponsored Medicaid programs. The cessation of pandemic-era policies has unveiled challenges that were once masked by continuous enrollment provisions and...

Continue Reading
VMX 2026: A Revolutionary Event for Animal Health Professionals

Updated Category News Views 108

VMX 2026: A Hub of Veterinary Innovation As the Orange County Convention Center fills with nearly 30,000 veterinary professionals, VMX 2026 stands out as the pivotal global veterinary conference. Over 85 countries are represented, creating an atmosphere buzzing with energy, ideas, and innovations. This annual gathering focuses on advancing veterinary care, reinforcing the...

Continue Reading
Innovative Partnership Enhances Maternal Health Support Services

Updated Category News Views 87

Pacify's New Collaboration with First Choice Pacify, a distinguished provider of maternity care solutions, is embarking on an exciting collaboration with First Choice by Select Health, a prominent Medicaid managed care plan in its state. This partnership aims to introduce technology-driven, doula-assisted maternal health services aimed at First Choice's qualifying...

Continue Reading
Vin Farrell Joins Omnicom Production as Head of Studio

Updated Category News Views 255

Omnicom Production Welcomes New Head of Studio Omnicom Production is excited to announce the appointment of Vin Farrell as its new Head of Studio. With a wealth of experience, Farrell is set to make a significant impact in this innovative role. Vin Farrell's Impressive Background Farrell brings three decades of production experience, paving the path for new methodologies...

Continue Reading
Top AI Stocks for Future Investment Potential

Updated Category News Views 180

Predictions for the Largest AI Stocks by 2035 As we look ahead to the evolving landscape of artificial intelligence (AI), it's important to identify which companies are likely to become market leaders. Reflecting on the significant advancements made since 2013, we can see how they have laid the groundwork for a promising future. In this article, we will examine three key...

Continue Reading